43 results on '"Sharma, Raman"'
Search Results
2. Surreptitious Area of Middle Ear - the Sinus Tympani
3. Ewing’s Sarcoma of Maxillary Sinus
4. Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI
5. Carotidynia - An Unexplored Entity in Otolaryngology Practice: Three Case Reports & Review of Literature
6. Clinical Profile, Intensive Care Needs and Predictors of Outcome Among Children Admitted with Non-COVID Severe Acute Respiratory Illness (SARI) During the Pandemic
7. Hypophosphatemia: A Common but Overlooked Cause of Cardiac Dysfunction in a Child with DKA
8. 'Maladapted' Public Transport Solutions: A Case of Amritsar in Punjab, India
9. Adsorption of Te clusters on tellurene and MoS2 monolayers: structural, electronic, and optical properties
10. Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention
11. Pharmacotherapy and revascularization strategies of peripheral artery disease
12. Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease
13. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
14. The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite
15. A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
16. Real-World Comparison of Clopidogrel With Ticagrelor and Prasugrel in Patients With Chronic Coronary Disease Who Underwent Atherectomy
17. Pharmacist-led interventions in optimising the use of oral anticoagulants in patients with atrial fibrillation in general practice in England: a retrospective observational study.
18. Single Center Outcomes of Percutaneous Deep Vein Arterialization in Patients with End-Stage Peripheral Artery Disease.
19. A Peculiar Case of Isolated Bilateral Tympanic Plate Fractures
20. Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
21. AMycobacterium tuberculosissecreted virulence factor disrupts host snRNP biogenesis
22. PPARγ mediated enhanced lipid biogenesis fuelsMycobacterium tuberculosisgrowth in hepatocytes.
23. The impact of COVID-19 on electronic repeat dispensing (eRD) in general practice
24. Voice Assistant and its OS Integration
25. Predictive Value of CT Perfusion Parameters in Traumatic Brain Injury Patients: A Longitudinal Study
26. F-49 | Long term outcomes according to lesion location and SYNTAX points, not attributed to the left main lesion, in patients undergoing percutaneous coronary intervention of the left main coronary artery
27. Hepatocyte formation, reactivity, and stability differences of acyl glucuronide and acyl coenzyme a conjugates
28. Predictors of Suboptimal Lumen Expansion Following Intravascular Lithotripsy for Coronary In-Stent Restenosis
29. The Drug-Drug Interaction between Erlotinib and OSI-930 Is Mediated through Aldehyde Oxidase Inhibition
30. Mitigating fire risks in hospitals: Are we primed and geared up?
31. Assessment of the Efficacy of an Automated AMBU Bag Operating Device (RC Device) in Patients Requiring Mechanical Ventilation: A Pilot Study
32. IVUS Improves Outcomes With SUPERA Stents for the Treatment of Superficial Femoral-Popliteal Artery Disease
33. DIRECT INTERVENTION IMPROVES MORTALITY AND AMPUTATION RATES IN PATIENTS WITH CHRONIC LIMB THREATENING ISCHEMIA.
34. The Reply.
35. ANGIOAID 3D : A NOVEL MOBILE BASED PLATFORM FOR SIMULATING DIAGNOSTIC CORONARY ANGIOGRAMS.
36. PROVISIONAL VS TWO-STENT STRATEGY IN THE TREATMENT OF TRUE BIFURCATION CORONARY LESIONS: OUTCOMES STRATIFIED BY LESION COMPLEXITY.
37. A NOVEL RISK SCORE TO PREDICT ONE-YEAR RISK OF MACE IN PATIENTS UNDERGOING CORONARY TRUE BIFURCATION INTERVENTION.
38. CLINICAL IMPACT OF PROCEDURAL COMPLEXITY AND HIGH BLEEDING RISK STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
39. IMPACT OF LEFT VENTRICULAR EJECTION FRACTION ON 1-YEAR OUTCOMES IN PATIENTS WITH END-STAGE RENAL DISEASE FOLLOWING PERCUTANEOUS CORONARY INTERVENTION.
40. IMPACT OF POLYVASCULAR DISEASE ON MORTALITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE.
41. OUTCOMES OF PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION STRATIFIED BY TREATMENT WITH OR WITHOUT GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONISTS.
42. INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION.
43. Impact of sex on outcomes associated with polyvascular disease in patients after PCI.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.